|4Jun 26, 3:32 PM ET

RxElite, Inc. 4

4 · RxElite, Inc. · Filed Jun 26, 2008

Insider Transaction Report

Form 4
Period: 2007-12-31
Sullivan Earl
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2007-12-31+25,00025,000 total
    Exercise: $0.76Exp: 2009-12-31Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]These options were granted pursuant to the 2007 Incentive Stock Plan which is subject to stockholder approval.
  • [F2]All of the options are subject to vesting and vest in full on December 31, 2008.

Documents

1 file
  • 4
    v118323_ex.xmlPrimary